Federal Register / Vol. 61, No. 17 / Thursday, January 25, 1996 / Notices 2255

‘‘decision-making and valuation for

environmental policy.’’ EPA, NSF, DOE,

and ONR intend to collaborate in an

RFA on bioremediation. Separate

solicitations on ‘‘endocrine disruptors’’

and ‘‘risk-based decisions for

contaminated sediments,’’ possibly

jointly with other agencies, will be

announced later.

Contacts for Research Topics of Interest

Ecological Assessment

• Robert Menzer 202–260–5779

menzer.robert@epamail.epa.gov

• Barbara Levinson 202–260–5983

levinson.barbara@epamail.epa.gov

Exposure of Children to Pesticides

• Chris Saint 202–260–1093

saint.chris@epamail.epa.gov

Air Quality

• Deran Pashayan 202–260–2606

pashayan.deran@epamail.epa.gov

Analytical and Monitoring Methods

• David Friedman 202–260–3535

friedman.david@epamail.epa.gov

Drinking Water

• Sheila Rosenthal 202–260–7334

rosenthal.sheila@epamail.epa.gov

Environmental Fate and Treatment of

Toxics and Hazardous Wastes

• William Stelz 202–260–5798

stelz.william@epamail.epa.gov

Environmental Statistics

• Chris Saint 202–260–1093

saint.chris@epamail.epa.gov

High Performance Computing

• Chris Saint 202–260–1093

saint.chris@epamail.epa.gov

Exploratory Research

• Clyde Bishop 202–260–5727

bishop.clyde@epamail.epa.gov

Dated: December 15, 1995.

Joseph Alexander,

Acting Assistant Administrator for Research

and Development.

[FR Doc. 96–1210 Filed 1–24–96; 8:45 am]

BILLING CODE 6560–50–P

GENERAL SERVICES

ADMINISTRATION

Interagency Committee for Medical

Records (ICMR) Stocking Change and

Revision of SF 531, Medical Record—

Anatomical Figure

AGENCY: General Services

Administration.

ACTION: Notice.

SUMMARY: The General Services

Administration/ICMR is changing the

stocking requirement of SF 531, Medical

Record—Anatomical Figure. This form

is now authorized for local

reproduction. You can request camera

copy of SF 531 from General Services

Administration (CARM), Attn.: Barbara

Williams, (202) 501–0581.

This form also is revised to:

1. To delete ‘‘grade; SSAN; rank;

rate;’’ from ‘‘PATIENT’S

IDENTIFICATION’’ item and replace

with ‘‘ID no. (SSN or other);’’.

FOR FURTHER INFORMATION CONTACT:

Mrs. Barbara Williams, General

Services Administration, (202) 501

0581.

EFFECTIVE DATE: January 25, 1996.

Dated: January 17, 1996.

Theodore D. Freed,

Chief, Forms Management Branch.

[FR Doc. 96–1089 Filed 1–24–96; 8:45 am]

BILLING CODE 6820–34–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

Advisory Committee Meeting;

Amendment of Notice

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing an

amendment to the notice of meeting of

the Vaccines and Related Biological

Products Advisory Committee. This

meeting was announced in the Federal

Register of December 27, 1995 (60 FR

66978 at 66979). The amendment is

being made to reflect a change in the

meeting place for the meeting. The

meeting times and agenda remain the

same.

FOR FURTHER INFORMATION CONTACT:

Sandy M. Salins or Nancy T. Cherry,

Center for Biologics Evaluation and

Research, Scientific Advisors and

Consultants Staff (HFM–21), Food and

Drug Administration, 1401 Rockville

Pike, Rockville, MD 20852, 301–827–

1294.

SUPPLEMENTARY INFORMATION: In the

Federal Register of December 27, 1995,

FDA announced that a meeting of the

Vaccines and Related Biological

Products Advisory Committee would be

held on January 29, 30, and 31, 1996.

On page 66979, in the first column, the

‘‘Date, time, and place’’ portion of the

meeting is amended to read as follows:

Date, time, and place. January 29, 30,

and 31, 1996, 8 a.m., DoubleTree Hotel,

Plaza Ballroom, 1750 Rockville Pike,

Rockville, MD.

Dated: January 22, 1996.

Michael A. Friedman,

Deputy Commissioner for Operations.

[FR Doc. 96–1320 Filed 1–23–96; 10:51 am]

BILLING CODE 4160–01–F

Open Meeting for Representatives of

Health Professional Organizations

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice of public meeting.

SUMMARY: The Food and Drug

Administration (FDA) is announcing an

open meeting with representatives of

health professional organizations. The

meeting will be chaired by Sharon

Smith Holston, Deputy Commissioner

for External Affairs. The agenda will

include brief presentations and

discussions on the topics of reinventing

government at FDA, MedWatch,

mandatory device reporting, salinefilled breast implants update, and other

topics.

DATES: The meeting will be held on

Monday, February 5, 1996, from 2 p.m.

to 4 p.m.

ADDRESSES: The meeting will be held at

the Hubert H. Humphrey Bldg., 200

Independence Ave. SW., conference

room 703A, Washington, DC 20201.

FOR FURTHER INFORMATION CONTACT:

Peter H. Rheinstein, Office of Health

Affairs (HFY–40), Food and Drug

Administration, 5600 Fishers Lane,

Rockville, MD 20857, 301–443–5470.

SUPPLEMENTARY INFORMATION: The

purpose of the meeting is to provide an

opportunity for representatives of health

professional organizations to be briefed

by senior FDA staff, and to provide an

opportunity for informal discussion and

comment on topics of particular interest

to health professional organizations.

Dated: January 17, 1996.

William K. Hubbard,

Associate Commissioner for Policy

Coordination.

[FR Doc. 96–1072 Filed 1–24–96; 8:45 am]

BILLING CODE 4160–01–F

Health Care Financing Administration

Public Information Collection

Requirements Submitted for Public

Comment and Recommendations

AGENCY: Health Care Financing

Administration, HHS.

In compliance with the requirement

of section 3506(c)(2)(A) of the

Paperwork Reduction Act of 1995, the